Patrick Flamen

Paget bone disease demonstrated on 68Ga-PSMA ligand PET/CT

R. Velthoven, Z. Wimana, F. Otte, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy

R. Velthoven, T. Gil, S. Albisinni, 2019, World Journal of Urology.

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity

D. Sze, S. Kappadath, P. Flamen, 2019, CardioVascular and Interventional Radiology.

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)

E. de Vries, C. W. Menke-van der Houven van Oordt, S. Stroobants, 2024, NPJ breast cancer.

BONE HEALTH IN CANCER: ESMO CLINICAL PRACTICE GUIDELINES.

M. Aapro, P. Flamen, J. Body, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Whole-body PET with FDG for the diagnosis of recurrent gastric cancer

A. Maes, L. Mortelmans, G. Bormans, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [89Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model

G. Doumont, B. Vanderlinden, G. V. Simaeys, 2015, Molecular Imaging and Biology.

Results from a phase I study of 4-l-[131I]iodo-phenylalanine ([131I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1)

J. Pichler, A. Braat, Patrick Flamen, 2024, Neuro-oncology advances.